Pharmaceutical Development and Drug Costs
Health and Human Services Secretary Sylvia Burwell delivered opening remarks at the department’s forum about the development of new pharmaceuticals and concerns about rising drug costs. Then…
622 viewsHealth and Human Services Secretary Sylvia Burwell delivered opening remarks at the department’s forum about the development of new pharmaceuticals and concerns about rising drug costs. Then…
622 viewsMark McClellan was interviewed about the Medicare drug benefits plan. Among the topics he addressed were savings from the plan, perceived problems by the public, and a surge in enrollment. F…
81 viewsAdministrator McClellan testified about promoting the use of generic drugs in the new Medicare drug benefit and about the savings incurred. He said that generics are as safe and effective as…
171 viewsPresident Bush talks to students and members of the public about the Medicare prescription drug benefit at a town hall meeting at Northern Virginia Community College. He was joined by Secret…
88 viewsGovernor Barbour, chairman of the Health and Human Services Committee of NGA, opened the session, followed by remarks by Governor Corzine, vice chair of the committee. Administrator McClella…
118 viewsAdministration officials and health care providers testified about Medicare drug benefit programs and the recent implementation of new rules to provide a wider range of coverage to recipient…
219 viewsDuring the National Black Caucus of State Legislators held its 29th Annual Legislative Conference, titled “Seeing Beyond: Investing in State Leadership, Improving Communities.” Mr. Swygert …
156 viewsHealth officials spoke to reporters about a community-based education program being launched by National Council on Aging and the Access to Benefits Coalition to help beneficiaries and their…
109 viewsIn an oversight hearing, the subcommittee heard testimony on the implementation of the Medicare prescription drug benefit program projected costs of the program, and the state of health care…
77 viewsThe Department of Health and Human Services' Task Force on Drug Importation hosted a public meeting focusing on drug importation issues. Members of the public made presentations to the Task …
179 viewsDr. Mark McClellan, the administrator of the Centers for Medicare and Medicaid Services, talked about health policy and new medical advances. Topics included Medicare legislation, main strea…
37 viewsDr. McClellan testified about prescription drug importation from both economic and health and safety perspectives. He talked about a task force being formed to study assuring the safety of i…
91 viewsSecretary Thompson and Mr. McClellan spoke to reporters about the decision to ban the dietary supplement Ephedra. They talked about the guidelines they used in reaching the decision and abou…
193 viewsMr. McClellan talked about food and drug related issues, including the safety of drug imports, protecting the U.S. food supply, and the likelihood that silicone breast implants would be re-a…
61 viewsOfficials talked about the safety of the U.S. food supply, focusing on actions designed to protect the food supply from terrorism. Two new rules were announced: food importers must give the …
36 viewsAttorneys representing major league sporting associations and government officials testified about the safety and use of the dietary supplement Ephedra. Among the topics they addressed were …
235 viewsDr. McClellan talked about the role of the FDA in protecting the public health, and FDA enforcement standards. New challenges facing the FDA included the increasing number and complexity of …
68 viewsSecretary Tommy Thompson and Mark McClellan talked about new rules to improve access to cheaper generic drugs and accelerating the process by which they are approved. Following their remarks…
46 viewsDr. McClellan talked about the food safety, the status of research at the FDA, and fulfilling the public health mission of the FDA. He also talked about regulating food safety and future saf…
37 viewsDr. Mark McClellan testified about his qualifications as administrator of the Food and Drug Administration. Among the topics he addressed were the placement of warning labels on products, dr…
69 views